Supernus Pharmaceuticals Stock (NASDAQ: SUPN) stock price, news, charts, stock research, profile.
Open | $26.49 |
Close | $25.77 |
Volume / Avg. | 271.08K / 564.73K |
Day Range | 25.66 - 26.49 |
52 Wk Range | 21.99 - 35.44 |
Market Cap | $1.41B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 16.19% |
Days to Cover | 10.41 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Supernus Pharmaceuticals (NASDAQ:SUPN) through any online brokerage.
Other companies in Supernus Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP), Neumora Therapeutics (NASDAQ:NMRA) and Longboard Pharmaceuticals (NASDAQ:LBPH).
There is no analysis for Supernus Pharmaceuticals.
Supernus Pharmaceuticals has a consensus price target of $41.00.
The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $25.71 last updated July 2, 2024 at 4:35 PM EDT.
There are no upcoming dividends for Supernus Pharmaceuticals.
Supernus Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Supernus Pharmaceuticals.
Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.